Trials / Completed
CompletedNCT03302559
Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage
Assessing the Cosmetic Changes in the Facial Skin Utilizing Non-Invasive In Vivo Skin Imaging Instrumentation After Use of a Topical Retinoid Product In Subjects With Moderate to Severe Photodamage
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the cosmetic changes of a cosmetic topical retinoid product in participants with moderate to severe photodamage utilizing non-invasive in vivo skin imaging instrumentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Retinol Complex 0.5 | Retinol Complex 0.5 topically in the evening. |
| OTHER | Facial cleanser | Facial cleanser in the morning and in the evening. |
| OTHER | Moisturizing lotion | Fragrance free moisturizing lotion in the morning and in the evening. |
| OTHER | Sunscreen | Sunscreen broad spectrum sun protection factor (SPF) 35 topically in the morning and as needed. |
| DEVICE | Skin Imaging | Non-invasive in vivo skin imaging will be taken with the VivoSight Dx Optical Coherence Tomography (OCT) and VivaScope 1500 |
Timeline
- Start date
- 2017-09-18
- Primary completion
- 2018-04-30
- Completion
- 2018-04-30
- First posted
- 2017-10-05
- Last updated
- 2019-06-04
- Results posted
- 2019-06-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03302559. Inclusion in this directory is not an endorsement.